Juan C. Jaen, SVP, Drug Discovery & CSO at ChemoCentryx, Inc. (CCXI), sold 12,599 shares at $13.14 ($161K) on 2013-02-28, disclosed to the SEC on 2013-03-01.
Scheduled sale ($161k) by SVP, Drug Discovery & CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.55 | 4,901 | $62K | 38.2% |
| 2 | $12.56 | 2,599 | $33K | 20.3% |
| 3 | $12.56 | 99 | $1K | 0.8% |
| 4 | $13.14 | 5,000 | $66K | 40.8% |
| Total | $12.79 avg | 12,599 | $161K | 100% |
| Filing → |
| RCUS | SELL | 2026-01-07 | $681K | — | Filing → |
| RCUS | SELL | 2025-12-18 | $688K | — | Filing → |
| RCUS | SELL | 2025-12-05 | $4.1M | — | Filing → |